ストックスクリーナーアプリを入手
0.96
2.19%
-0.0215
アフターアワーズ：
.97
0.01
+1.04%
前日終値:
$0.9815
開ける：
$0.96
24時間の取引高:
43,949
Relative Volume:
0.36
時価総額：
$43.34M
収益：
$80.28M
当期純損益:
$-38.83M
株価収益率:
-1.1541
EPS:
-0.8318
ネットキャッシュフロー:
$-28.67M
1週間 パフォーマンス:
-11.93%
1か月 パフォーマンス:
-23.81%
6か月 パフォーマンス:
+20.05%
1年 パフォーマンス:
-35.14%
1日の値動き範囲:
$0.96
$1.0899
1週間の範囲:
$0.96
$1.09
52週間の値動き範囲:
$0.5011
$1.505
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.96 | 43.34M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
103.10 | 178.40B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.95 | 120.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
301.42 | 115.62B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.06 | 65.30B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.82 | 52.35B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-09-25 | 開始されました | Craig Hallum | Buy |
| 2025-03-21 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 開始されました | Lake Street | Buy |
| 2019-12-03 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-12-03 | 開始されました | Jefferies | Buy |
| 2019-12-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Tela Bio Inc (TELA) 最新ニュース
Form 4 Tela Bio Inc: Joseph H. Capper (Director) For: 15 October By Investing.com - Investing.com South Africa
Form 4 Tela Bio Inc: William J. Plovanic (Director) For: 15 October - Investing.com Canada
Form 4 Tela Bio Inc: Joseph H. Capper (Director) For: 15 October - Investing.com UK
Stock replaces cash pay for TELA Bio (TELA) director in 19,801-share award. - Stock Titan
TELA Bio (TELA) director William J. Plovanic receives 16,089 shares instead of cash compensation. - Stock Titan
TELA Bio Regains Nasdaq Compliance, Securing Listing Status - The Globe and Mail
TELA Bio Achieves Nasdaq Minimum Bid Price Compliance, Listing Issue Resolved - Kalkine Media
TELA Bio regains Nasdaq Global Market minimum bid price compliance - TradingView
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement - GlobeNewswire Inc.
TELA Bio Faces Nasdaq Delisting, Plans Reverse Split - TipRanks
TELA Bio (TELA) director buys shares outside trading plan - Stock Titan
TELA Bio Received Notice of Delisting - TradingView
Tela Bio director Capper acquires $78,442 in company stock By Investing.com - Investing.com UK
Tela Bio director Capper acquires $78,442 in company stock - Investing.com
TELA Bio (TELA) director adds to stake in open-market buys - Stock Titan
Reverse split of up to 1-for-15 heads to a vote at TELA Bio (NASDAQ: TELA) after Nasdaq bid-price warning - Stock Titan
TELA Bio Inc. (TELA) Edges Higher on Renewed Buying Interest Near Key Support ZoneMoving Average Crossovers - dars.gov.et
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com South Africa
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position - MyChesCo
Malvern's TELA Bio Cuts Costs 18% and Parts Ways With Longtime COO/CFO Roberto Cuca - BioBuzz
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Nigeria
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Australia
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Canada
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com India
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com UK
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
TELA Bio Cuts Annual Costs by $17 Million as COO-CFO Departs - citybiz
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com India
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com Canada
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com South Africa
TELA Looks 52.3% Undervalued on GF Value™ Despite Operational Ch - GuruFocus
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com Nigeria
TELA Bio Implements Workforce Cuts and Leadership Changes - TipRanks
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com UK
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative - GlobeNewswire
TELA Bio is cutting about 20% of its headcount to save $17 million a year - Stock Titan
Tela Bio Inc (TELA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Canada
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Nigeria
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayChandelier Stop - siam.in
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stake -- Shares Trade 55% Below GF Value - GuruFocus
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
Tela Bio Inc (TELA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Capper Joseph H | Director |
Sep 17 '26 |
Buy |
1.22 |
25,000 |
30,530 |
179,827 |
| Capper Joseph H | Director |
Sep 15 '26 |
Buy |
1.06 |
50,000 |
52,940 |
104,827 |
| Capper Joseph H | Director |
Sep 14 '26 |
Buy |
1.02 |
25,000 |
25,502 |
54,827 |
| Getz Heather C | Chief Executive Officer |
Aug 17 '26 |
Buy |
0.66 |
12,500 |
8,311 |
532,500 |
| Getz Heather C | Chief Executive Officer |
Aug 14 '26 |
Buy |
0.70 |
15,000 |
10,467 |
520,000 |
| EW HEALTHCARE PARTNERS FUND 2, | 10% Owner |
Nov 17 '25 |
Buy |
1.11 |
3,604,000 |
4,000,440 |
7,714,709 |
1.18%
1.06%
大文字化:
|
ボリューム (24 時間):